fluorescein-5-isothiocyanate has been researched along with Lymphoma, Large-Cell, Anaplastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bobos, M; Kaloutsi, V; Karayannopoulou, G; Kostopoulos, I; Kotoula, V; Papadimitriou, CS | 1 |
| Ambrogio, C; Chiarle, R; D'Escamard, V; Forni, G; Inghirami, G; Martinengo, C; Mastini, C | 1 |
2 other study(ies) available for fluorescein-5-isothiocyanate and Lymphoma, Large-Cell, Anaplastic
| Article | Year |
|---|---|
Aberrant CCND1 copies and cyclin D1 mRNA expression do not result in the production of functional cyclin D1 protein in anaplastic large cell lymphoma.
Topics: Adolescent; Adult; Aged; Child; Chromosomes, Human, Pair 11; Cyclin D1; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Gene Dosage; Gene Expression; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Indoles; Ki-1 Antigen; Lymphoma, Large-Cell, Anaplastic; Male; Middle Aged; Rhodamines; RNA, Messenger; Young Adult | 2009 |
The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination.
Topics: Anaplastic Lymphoma Kinase; Animals; Antigens, Neoplasm; Cell Line, Transformed; Cell Line, Tumor; Cell Transformation, Neoplastic; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique, Direct; Fluorescent Dyes; Immunization, Secondary; Immunohistochemistry; Lymphoma, Large-Cell, Anaplastic; Mice; Mice, Inbred BALB C; Mice, Transgenic; Mutation; Plasmids; Protein-Tyrosine Kinases; Receptor Protein-Tyrosine Kinases; Vaccination | 2008 |